Human lung adrenoreceptors studied by radioligand binding.

Area of Science:

• Pharmacology
• Pulmonary Medicine
• Molecular Biology

Background:

• Adrenoreceptors play a crucial role in regulating airway function.
• Understanding the specific subtypes and distribution of adrenoreceptors in human lung tissue is essential for developing targeted therapies for respiratory diseases.

Purpose of the Study:

• To characterize and quantify alpha- and beta-adrenoreceptor sites in human peripheral lung tissue.
• To investigate the predominant beta-adrenoreceptor subtype in the human lung.
• To assess adrenoreceptor characteristics in patients with obstructive airways disease.

Main Methods:

• Direct radioligand-binding techniques were employed using [3H]dihydroalprenolol for beta-adrenoreceptor sites and [3H]prazosin for alpha-adrenoreceptor sites.
• Lung tissue samples were obtained from ten patients undergoing thoracotomy, with nine diagnosed with obstructive airways disease.
• Binding characteristics including saturability, affinity, kinetics, reversibility, and stereospecificity were evaluated.

Main Results:

• Both [3H]dihydroalprenolol and [3H]prazosin binding demonstrated high affinity, rapid kinetics, saturability, reversibility, and stereospecificity.
• The observed rank order of agonists and antagonists correlated well with known physiological potencies, validating the binding assays.
• Specificity of [3H]dihydroalprenolol binding indicated that the beta-adrenoreceptor population in the human lung is primarily of the beta 2 subtype.

Conclusions:

• Human peripheral lung tissue possesses specific alpha- and beta-adrenoreceptor sites characterized by high affinity and appropriate binding kinetics.
• The predominant beta-adrenoreceptor subtype in the human lung is the beta 2 subtype.
• These findings contribute to the understanding of lung adrenoreceptor pharmacology, relevant for conditions like obstructive airways disease.